Industry NewsCOVID-19 therapeutic treatment is world's first synthetic biological drug to receive FDA approval for phase III trials
Industry NewsTomocube microscope quantifies effectiveness of experimental nanodrugs against biggest killer in westernised societies
Industry NewsCobra Biologics selected to manufacture plasmids for Phase I clinical trial of Scancell’s COVID-19 vaccine in 2021
Product NewsCancer genomic screening program LC-SCRUM-Asia adopts latest Thermo Fisher Scientific NGS solutions